If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Regulatory News (VRP)

  • There is currently no data for VRP

Statement Regarding Share Price Movement

4 Jan 2013 14:59

VERONA PHARMA PLC - Statement Regarding Share Price Movement

VERONA PHARMA PLC - Statement Regarding Share Price Movement

PR Newswire

London, January 4

Verona Pharma plc("Verona" or the "Company")

Statement regarding share price movement

The Company notes the recent share price movement. The Board of Verona is notaware of any reason that would lead to such a movement in the Company's shareprice. In addition, it now currently anticipates that the result of the RPL554anti inflammatory trial, previously expected around year end, will not beavailable until March 2013.

For further information please contact:

Jan-Anders Karlsson, Verona Pharma plc Tel: 020 7863 3300

Chris Fielding, WH Ireland Limited Tel: 020 7220 1650

Date   Source Headline
23rd Aug 20067:01 amRNSRestoration - ISIS Resources
23rd Aug 20067:01 amRNSAcquisition and Placing
3rd May 200610:34 amRNSFinal Results
3rd Apr 20067:01 amRNSSuspension - ISIS Resources
3rd Apr 20067:01 amRNSSuspension of shares
9th Mar 20069:40 amRNSAppointment of NOMAD
28th Sep 200510:01 amRNSInterim Results
30th Aug 200511:29 amRNSConversion of Securities
31st May 20057:02 amRNSIssue of Equity
30th Mar 20059:12 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.